MPM BIOIMPACT LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 1687078 BOSTON, MA

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$31,287,647

-$2,470,921 QoQ

Shares Held

1,606,967

-11.3% QoQ

Ownership

1.89%

of shares outstanding

% of Portfolio

1.91%

of 13F equity value

Holder Rank

#11

of 172 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MPM BIOIMPACT LLC holds $1,463,416,616 across 34 Biotechnology names. MLTX ranks #17 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CGEM	Cullinan Therapeutics, Inc.	9,731,341	$177,207,719
2	AKTS	Aktis Oncology, Inc.	4,835,872	$155,860,154
3	RVMD	Revolution Medicines, Inc.	492,483	$92,232,216
4	CORT	Corcept Therapeutics Inc	771,028	$67,040,884
5	EWTX	Edgewise Therapeutics, Inc.	1,620,780	$65,852,291
6	TVTX	Travere Therapeutics, Inc.	1,122,731	$63,782,348
7	DBVT	DBV Technologies S.A.	3,666,284	$60,127,057
8	TRVI	Trevi Therapeutics, Inc.	3,073,577	$57,322,211

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,287,647	1,606,967	-11.3%	Shares	Sole	2026-08-14
2026-03-31	$33,758,568	1,811,082	+477.6%	Shares	Sole	2026-05-15
2025-06-30	$14,800,551	313,571	-0.8%	Shares	Sole	2025-08-14
2025-03-31	$12,348,034	316,049	+0.3%	Shares	Sole	2025-05-15
2024-12-31	$17,069,704	315,230	-9.7%	Shares	Sole	2025-02-14
2024-09-30	$17,599,756	349,063	+1.7%	Shares	Sole	2024-11-13
2024-06-30	$15,092,042	343,235	+15.9%	Shares	Sole	2024-08-14
2024-03-31	$14,870,591	296,050	+0.5%	Shares	Sole	2024-05-15
2023-12-31	$17,789,444	294,576	+0.1%	Shares	Sole	2024-02-13
2023-09-30	$16,768,830	294,190	-0.3%	Shares	Sole	2023-11-14
2023-06-30	$15,050,661	295,111	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.